Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 23/30 August 2014, Vol 293, No 7824/5

Sort by: Newest first Oldest first A-Z Z-A

  • Aamer Safdar working on his computer

    Advising young people on a career in healthcare Subscription

    21 AUG 2014 By Aamer Safdar

    A new online programme enables NHS staff to connect with teenagers and help them consider their career options.

  • Painting of an 18th century apothecary

    Non-evidence-based products have no place in community pharmacies Subscription

    21 AUG 2014 By Anthony Cox
    Comments (6)

    Pharmacists should leave quackery in the past and focus on evidence of efficacy when selling over-the-counter drugs.

  • Tramadol abuse

    Decision to control tramadol results from learning how it is used or abused

    21 AUG 2014

    The dangers of addiction to the opioid, which were not anticipated at the drug’s launch, serve as a reminder that pharmacists always have more to learn.

  • Ensure that no counterfeit medicines enter the supply chain Subscription

    21 AUG 2014 By Peter McAuley
    Comments (1)

    I would like to comment on the news item in The Pharmaceutical Journal regarding falsified medicines (2014;293:100). The piece claims that the time taken to test whether a pack is counterfeit will be less than a second.

  • Ill-judged treatment for dementia patients cannot continue

    21 AUG 2014

    As reports of inappropriate prescribing for dementia patients continue to increase, it is crucial that the issue is taken seriously.

  • Pharmacists responding to international crises Subscription

    21 AUG 2014 By Trudi Hilton

    Many pharmacists and companies have made contact with International Health Partners (IHP) over the past few weeks looking for ways to make an impact on the huge need in so many conflict zones and disasters around the world.

  • Light micrograph of uric acid crystals from a gouty joint

    Acute management and prevention of gout Subscription

    21 AUG 2014 By Tina Hawkins
    Comments (5)

    Ways to treat this painful condition that affects almost 900,000 people in the UK and how lifestyle changes can prevent further attacks.

  • Medicines adherence course Subscription

    19 AUG 2014 18:58

    FutureLearn, a free educational platform, is running a second course on medicines adherence between 25 August and 7 September 2014, following the success of the same course run in April. The content of the course has been created with the help of specialists at King’s College London. The course is designed for healthcare professionals. Participants can register for free until 7 September ...

  • Tasigna side effects Subscription

    19 AUG 2014 18:54

    The frequency and occurence of side-effects associated with Tasigna (nilotinib; Novartis), has been updated in the product’s summary of product characteristics. Leukopenia, hypocalcaemia, hypokalaemia, myocardial infarction, eczema, muscular weakness and decreased globulins are all now listed as common adverse events. Ischaemic stroke, cerebral infarction and cardiac failure are now listed as uncommon adverse events. Cerebrovascular accident, peripheral artery stenosis and basilar artery ...

  • We need to balance the scale of change for pharmacy inspections Subscription

    19 AUG 2014 8:36 By Robert Darracott

    Richard Schmidt (2014;293:151) has provided a well argued response to the central tenet of Graham Phillips’s blog (2014;293:151) about the new General Pharmaceutical Council inspection process — that ...

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.